Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Sees Significant Growth in Short Interest

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) was the target of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 3,660 shares, an increase of 3,752.6% from the February 12th total of 95 shares. Approximately 1.5% of the shares of the company are short sold. Based on an average daily trading volume, of 3,171 shares, the short-interest ratio is presently 1.2 days. Based on an average daily trading volume, of 3,171 shares, the short-interest ratio is presently 1.2 days. Approximately 1.5% of the shares of the company are short sold.

Bitwise MARA Option Income Strategy ETF Trading Down 0.1%

IMRA traded down $0.02 during trading on Tuesday, hitting $13.75. The stock had a trading volume of 12,037 shares, compared to its average volume of 6,073. The firm has a market cap of $3.30 million, a PE ratio of 275.00 and a beta of -6.67. Bitwise MARA Option Income Strategy ETF has a 12 month low of $11.99 and a 12 month high of $60.73. The company has a 50 day simple moving average of $15.05 and a 200-day simple moving average of $24.44.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.